Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-76.29	3.85	16.24
Graham Fair Price	-41.40	3676.84	6274.73
PEG	225.95	-0.48	0.15
Price/Book	-32.14	0.43	0.63
Price/Cash Flow	-44.71	-6.70	12.12
Prices/Earnings	273.04	35.81	9.60
Price/Sales	-33.35	0.81	1.21
Price/FCF	-44.71	-6.70	12.12
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	10.83	0.22	0.20
Operating Margin	22.94	0.07	0.05
ROA	-82.48	< 0.005	< 0.005
ROE	0.02	< 0.005	-81.81
ROIC	0.02	0.02	-14.35
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.29	-0.10	200.45
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.23	0.23	-0.16
EPS QOQ	0.66	-0.75	14.45
FCF QOQ	5.07	-2.21	-56.43
Revenue QOQ	-0.06	< 0.005	-95.96
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	55.71	63.19	13.43
Days Sales Outstanding (DSO)	49.32	50.75	2.90
Inventory Turnover	1.62	1.42	-11.84
Debt/Capitalization	0.20	0.24	24.10
Quick Ratio	1.18	1.12	-5.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10337.42	14202.54	37.39
Cash	3595.66	5293.40	47.22
Capex	-209.58	-349.83	-66.91
Free Cash Flow	536.23	-904.13	68.61
Revenue	5350.82	7485.07	39.89
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.71	1.64	-4.09
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.35	0.24	-81.98
Naive Interpretation	Member

06 - Financial Health · Weak

Rating